glp-1 telehealth is Making GLP-1s More Accessible – But Access Alone isn't Enough. Providing access to GLP-1s only solves part of the problem. In fact, without a broader approach, it may lead to Start your weight loss journey

many clinical trials used 600 mg to 2 g/day

Mounjaro is a comprehensive approach to weight loss as it covers FIVE different areas in the insulin cycle

Schwartzberg L, Barbour SY, Morrow GR, Ballinari G, Thorn MD, Cox D

Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG , Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR

This week it is atai Life Sciences and Beckley Psytech reporting the positive results from their Phase 2a open-label study evaluating BPL-003 in Patients with Treatment Resistant Depression

Ferberyou each bring such warmth, wisdom, and professionalism to everything you do